Literature DB >> 9545318

Kinesin is a candidate for cross-bridging microtubules and intermediate filaments. Selective binding of kinesin to detyrosinated tubulin and vimentin.

G Liao1, G G Gundersen.   

Abstract

We showed previously that stable, detyrosinated (Glu) microtubules function to localize vimentin intermediate filaments in fibroblasts (Gurland, G., and Gundersen, G. G. (1995) J. Cell Biol. 131, 1275-1290). To identify candidate proteins that mediate the Glu microtubule-vimentin interaction, we incubated microtubules with microtubule-interacting proteins and saturating levels of antibodies to Glu or tyrosinated (Tyr) tubulin. Antibodies to Glu tubulin prevented the microtubule binding of kinesin obtained from fibroblast or brain extracts more effectively than antibodies to Tyr tubulin. Scatchard plot analysis showed that kinesin heads bound to Glu microtubules with an approximately 2.8-fold higher affinity than to Tyr microtubules. Purified brain kinesin cosedimented with vimentin, but not with neurofilaments, indicating that kinesin specifically associates with vimentin without accessory molecules. Kinesin binding to vimentin was not sensitive to ATP, and kinesin heads failed to bind to vimentin. By SDS-polyacrylamide gel electrophoresis, a kinesin heavy chain of approximately 120 kDa and a light chain of approximately 64 kDa were detected in vimentin/kinesin pellets. The light chain reacted with a general kinesin light chain antibody, but not with two other antibodies that recognize the two known isoforms of kinesin light chain in brain, suggesting that the kinesin involved in binding to vimentin may be a specific one. These results demonstrate a kinesin-based mechanism for the preferential interaction of vimentin with detyrosinated microtubules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545318     DOI: 10.1074/jbc.273.16.9797

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  102 in total

Review 1.  Intermediate filaments in motion: observations of intermediate filaments in cells using green fluorescent protein-vimentin.

Authors:  J L Martys; C L Ho; R K Liem; G G Gundersen
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

2.  Rapid intermittent movement of axonal neurofilaments observed by fluorescence photobleaching.

Authors:  L Wang; A Brown
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

3.  Bidirectional intracellular transport: utility and mechanism.

Authors:  Amber L Jolly; Vladimir I Gelfand
Journal:  Biochem Soc Trans       Date:  2011-10       Impact factor: 5.407

4.  Microtubule composition: cryptography of dynamic polymers.

Authors:  Kerry Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-27       Impact factor: 11.205

Review 5.  Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions.

Authors:  Carsten Janke; Jeannette Chloë Bulinski
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-16       Impact factor: 94.444

Review 6.  Post-translational modifications of microtubules.

Authors:  Dorota Wloga; Jacek Gaertig
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

7.  An Atypical Tropomyosin in Drosophila with Intermediate Filament-like Properties.

Authors:  Aeri Cho; Masato Kato; Tess Whitwam; Ji Hoon Kim; Denise J Montell
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

Review 8.  Back on track - on the role of the microtubule for kinesin motility and cellular function.

Authors:  Stefan Lakämper; Edgar Meyhöfer
Journal:  J Muscle Res Cell Motil       Date:  2006-02-02       Impact factor: 2.698

Review 9.  Alcohol-induced protein hyperacetylation: mechanisms and consequences.

Authors:  Blythe D Shepard; Pamela L Tuma
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

10.  Transport of African swine fever virus from assembly sites to the plasma membrane is dependent on microtubules and conventional kinesin.

Authors:  Nolwenn Jouvenet; Paul Monaghan; Michael Way; Thomas Wileman
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.